BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21035129)

  • 1. Pediatric non-high-density lipoprotein cholesterol, the metabolic syndrome, and insulin resistance.
    Glueck CJ; Morrison JA
    J Pediatr; 2011 Feb; 158(2):179-81. PubMed ID: 21035129
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years.
    Li C; Ford ES; McBride PE; Kwiterovich PO; McCrindle BW; Gidding SS
    J Pediatr; 2011 Feb; 158(2):201-7. PubMed ID: 20828715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size.
    Arisaka O; Kariya K; Ichikawa G
    J Pediatr; 2012 Mar; 160(3):531-2; author reply 532. PubMed ID: 22217472
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers.
    Choi YS; Klaric JS; Beltran TH
    Metab Syndr Relat Disord; 2019 Feb; 17(1):37-45. PubMed ID: 30394863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
    Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
    J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.
    Martin SS; Giugliano RP; Murphy SA; Wasserman SM; Stein EA; Ceška R; López-Miranda J; Georgiev B; Lorenzatti AJ; Tikkanen MJ; Sever PS; Keech AC; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2018 Aug; 3(8):749-753. PubMed ID: 29898218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?
    Lind L; Ingelsson E; Ärnlöv J; Sundström J; Zethelius B; Reaven GM
    Metab Syndr Relat Disord; 2018 Oct; 16(8):433-439. PubMed ID: 30183521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Triglyceride/High-Density Lipoprotein Cholesterol Index with Insulin Resistance in a Pediatric Population in Northeast Mexico.
    Rodríguez-Gutiérrez N; Vanoye Tamez M; Vázquez-Garza E; Villarreal-Calderón JR; Castillo EC; Laresgoiti-Servitje E; Elizondo-Montemayor L; García-Rivas G
    Metab Syndr Relat Disord; 2020 Sep; 18(7):333-340. PubMed ID: 32552368
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin Levels Are Associated with Cardiometabolic Risk Factors in Euthyroid Adolescents.
    Le TN; Celi FS; Wickham EP
    Thyroid; 2016 Oct; 26(10):1441-1449. PubMed ID: 27599541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda.
    Kavishe B; Vanobberghen F; Katende D; Kapiga S; Munderi P; Baisley K; Biraro S; Mosha N; Mutungi G; Mghamba J; Hughes P; Smeeth L; Grosskurth H; Peck R
    PLoS One; 2019; 14(12):e0223189. PubMed ID: 31809516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk.
    Ley SH; Harris SB; Connelly PW; Mamakeesick M; Gittelsohn J; Wolever TM; Hegele RA; Zinman B; Hanley AJ
    Diabetes Obes Metab; 2012 Sep; 14(9):821-5. PubMed ID: 22510237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
    Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
    Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia.
    Falko JM; Moser RJ; Meis SB; Caulin-Glaser T
    Curr Diabetes Rev; 2005 May; 1(2):127-35. PubMed ID: 18220588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.
    Qualls LG; Hammill BG; Maciejewski ML; Curtis LH; Jones WS
    Diab Vasc Dis Res; 2016 May; 13(3):244-6. PubMed ID: 26802221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.